江南大学坐落于江苏省无锡市，是教育部直属、国家“211工程”重点建设高校和一流学科建设高校。

During the past decade, Jiangnan University conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jiangnan University" #1 collaborator was "Affiliated Hospital of Jiangnan University" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Jiangnan University" are "Castration-resistant Prostate Cancer" (2 trials). Many other conditions were trialed in "Jiangnan University" in a lesser frequency.

Most popular intervention types in "Jiangnan University" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone" (2 trials), "Coenzyme A Combined With Abiraterone" (1 trials) and "Polaprezinc" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jiangnan University" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Jiangnan University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Jiangnan University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jiangnan University, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".